semaglutide bs tirzepatide vs. Semaglutide: Key Differences & Benefits Retatrutide vs Tirzepatide vs Semaglutide

Retatrutide is under clinical development as a treatment for obesity, type 2 diabetes, and related metabolic conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease)

Potential Benefits for Cardiovascular and Liver Health Phase 2 data showed reductions in liver fat content on MRI, relevant to MASLD, but dedicated cardiovascular outcomes trials have not yet been completed and cardiovascular benefits remain unconfirmed

The product referenced in this article, Bioma Probiotic for Weight Loss, is not intended to diagnose, treat, cure, or prevent any disease

The former was approved for type 2 diabetes in 2017